Horizant and Pulmicort drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Horizant (gabapentin enacarbil) and Pulmicort (budesonide). Common drug interactions include cellulitis among females and cardiac failure congestive among males.

The phase IV clinical study analyzes what interactions people have when they take Horizant and Pulmicort. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Horizant?

Horizant has active ingredients of gabapentin enacarbil. It is often used in restless leg syndrome. eHealthMe is studying from 2,051 Horizant users. Check the latest studies of Horizant.

What is Pulmicort?

Pulmicort has active ingredients of budesonide. It is often used in asthma. eHealthMe is studying from 34,980 Pulmicort users. Check the latest studies of Pulmicort.

On Jul, 10, 2026

11 people who take Horizant and Pulmicort together, and have interactions are studied.

Horizant and Pulmicort drug interactions.

What are the common drug interactions of Horizant and Pulmicort, by gender? *:

female:

Cellulitis (infection under the skin)
Eye swelling
Fatigue (feeling of tiredness)
Gastrointestinal disorder (functional problems of gastrointestinal tract)
Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
Infection
Infusion site mass
Ligament sprain (ligament stretched)
Middle ear effusion (fluid in middle ear)
Mitral valve prolapse (heart's mitral valve doesn't work well)

male:

Cardiac failure congestive
Hypertension (high blood pressure)
Pulmonary embolism (blockage of the main artery of the lung)
Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
Cardiomyopathy (weakening of the heart muscle)
Oedema peripheral (superficial swelling)
Sleep disorder

What are the common drug interactions of Horizant and Pulmicort, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Drug ineffective
Ligament sprain (ligament stretched)
Sinusitis (inflammation of sinus)
Somnolence (a state of near-sleep, a strong desire for sleep)

40-49:

n/a

50-59:

Infusion site mass
Middle ear effusion (fluid in middle ear)
Pyrexia (fever)
Road traffic accident
Sinus disorder (disease of sinus)
Sinusitis (inflammation of sinus)
Upper respiratory tract infection
Hereditary angioedema (recurrent episodes of severe swelling)
Injection site pain
Peripheral swelling

60+:

Cardiac failure congestive
Hypertension (high blood pressure)
Pulmonary embolism (blockage of the main artery of the lung)
Sleep apnoea syndrome (a sleep-related disorder in which the effort to breathe is diminished or absent)
Cardiomyopathy (weakening of the heart muscle)
Oedema peripheral (superficial swelling)
Sleep disorder

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 9 people, 81.82%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 7 people, 63.64%
Immunodeficiency Common Variable: 2 people, 18.18%
Immune System Disorder: 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Horizant and Pulmicort?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously